Navigation Links
SPRI Clinical Trials Now Enrolling Patients for Study of New Treatment for Depression
Date:10/15/2007

Patient Recruitment Starting Now -- For More Information, Call 888-345-7774

or Visit Our Website at http://www.spristudy.com

NEW YORK, Oct. 15 /PRNewswire/ -- SPRI Clinical Trials announced today that it is now screening patients for enrollment in the parAGOn Clinical Trial Program, which will start with two Phase III studies to evaluate the efficacy, safety and tolerability of agomelatine, a novel, investigational, once-daily medication for the treatment of Major Depressive Disorder (MDD). The 8-week, randomized, placebo-controlled studies are sponsored by Novartis Pharmaceuticals Corporation, and each of the two Phase III studies will include 490 patients from approximately 50 centers.

This investigational new drug targets both melatonin receptors and serotonin (5-HT2c) receptors.

The parAGOn Clinical Trial Program is open to patients between the ages of 18 and 70 who are experiencing MDD and meet other eligibility criteria. Eligible patients will be equally randomized to receive either treatment with agomelatine 25 mg, agomelatine 50 mg or placebo once daily for 8 weeks. Patients who complete the eight-week double-blind treatment phase may also participate in a 52-week open-label extension of the study.

MDD is the most common mood disorder, affecting approximately 15 million American adults, according to the National Alliance on Mental Illness. Common symptoms include: depressed mood, loss of interest in daily activities, poor concentration, weight loss (or gain), decrease of appetite, sleep disturbance, feelings of worthlessness and /or of guilt, and suicidal ideation. Episodes of depression may be chronic and recurrent, according to the National Institute of Mental Health.

Contact Dr. Nick Vatakis at 888-345-7774 for more information about the ParAGOn Clinical Trial Program.


'/>"/>
SOURCE SPRI Clinical Trials
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015 Following yesterday,s release of ... D, here are five things you need to know: ... market-based structure is unique among government programs. ... D is different than other parts of Medicare and other ... that submit bids to offer prescription drug benefits to enrollees. ...
(Date:5/1/2015)... , May 1, 2015  Portal Instruments, Inc., an ... systems, announced today that Robert Langer, Sc. D., ... University of Auckland Distinguished Professor have joined the company,s ... welcome two esteemed biotechnology leaders, Professor Robert Langer ... team," said Dr. Patrick Anquetil , Chief Executive ...
(Date:5/1/2015)... Heska Corporation (NASDAQ: HSKA - News ... veterinary diagnostic and other specialty veterinary products , today announced ... the 16th Annual B. Riley & Co. Investor Conference at ... be held May 12-14, 2015 at Lowes Hollywood Hotel, ... available during the day on May 13 for one-on-one meetings. ...
Breaking Medicine Technology:5 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 2Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 3Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 4Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2
... (AMS) (Nasdaq: AMMD ), a leading provider ... pelvic health, today announced the results of a six-month ... Prolapse Repair System. The pelvic organ prolapse quantification exam ... was implemented in the study and concluded efficacy rates ...
... March 10, 2011 Avaxia Biologics, Inc., a ... to develop orally-active antibody therapeutics for the treatment ... been awarded a Phase I Small Business Innovation ... Diabetes and Digestive and Kidney Diseases of the ...
Cached Medicine Technology:Six-Month Prospective Multi-Center Study Reports Efficacy Rates for AMS' Elevate Anterior and Apical Prolapse Repair System 2Avaxia Biologics Awarded Phase I SBIR Grant to Develop Oral Antibody Therapeutic for Celiac Disease 2
(Date:5/2/2015)... (PRWEB) May 03, 2015 As one ... of the prestigious Safety and Health Achievement and Recognition ... honored to be chosen by the Illinois Department of ... has achieved and maintained SHARP certification by the Occupational ... 2006, as Essentra has continued to meet or exceed ...
(Date:5/2/2015)... NY (PRWEB) May 02, 2015 It’s ... a deadly natural disaster strikes anywhere on this planet, ... leverage human sympathy and compassion for their own personal ... States Computer Emergency Readiness Team) issued an alert ... “of potential email scams citing the earthquake in Nepal. ...
(Date:5/2/2015)... 2015 As a nonsurgical staple ... the face, neck and décolleté, radiofrequency energy is ... potential for the success of vulvovaginal rejuvenation. In ... Advisory Council, ThermiGyn’s Women’s Health Clinical Advisory Board ... that ThermiGyn’s temperature controlled radio frequency, specifically that ...
(Date:5/1/2015)... May 01, 2015 Pioneer Millworks, the ... the latest in their reclaimed wood products at the ... Jacob Javits Center in NYC this May. Their newest ... bring much anticipated texture and color to North America's ... explosion of texture and color in the design world ...
(Date:5/1/2015)... 2015 It’s raining bills on Capitol Hill ... to expand federal support for telemedicine. , “Such ... been working with Congress,” said Jonathan Linkous, CEO of the ... nation is poised to embrace the use of telecommunications in ... in fulfilling ATA’s mission to improve quality, access, equity and ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2
... , ... email encryption provider, today announced that the company,s email encryption gateway now supports Red Hat ... www.djigzo.com . Djigzo can be installed using any of the provided packages for Ubuntu Linux, ... Workstation is available as well. , ...
... PRINCETON, N.J. , Jan. 13 A new ... $218 billion in 2007, with the exploding number of cases ... The National Changing Diabetes ® Program (NCDP), a program of ... article today in Health Affairs and performed by researchers ...
... ... onset of symptoms? One clever way to know for sure is to take snapshots of ... the patients over the years to see whether the diagnosis was correct. About 10 to ... , ...
... , WASHINGTON , Jan. ... issued the following statement today on a news ... largest insurance companies funneled between $10 million ... of Commerce to fund deceptive television ads opposing ...
... ... checks to their long list of services. ANY LAB TEST NOW® is a direct ... to Dallas residents. , ... January 12, 2009 -- ANY LAB TEST NOW® North Dallas announces web portal launch for providing ...
... , , BOSTON , Jan. 12 Americans ... in the Boston media market to educate Americans about ... $200,000 campaign, which will launch on Wednesday, January ... Americans for Responsible Heath Care television ads will remind the people ...
Cached Medicine News:Health News:Djigzo, an Open Source Email Encryption Provider, Today Announced That the Company's Encryption Gateway Now Supports Red Hat Linux 2Health News:Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates 2Health News:Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates 3Health News:Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates 4Health News:PET Scans May Help Diagnose Movement Disorders 2Health News:PET Scans May Help Diagnose Movement Disorders 3Health News:Pelosi: 'Insurance Industry Has Spent Millions of Dollars on Wrong Side of History' by Secretly Funding Deceptive Ads 2Health News:ANY LAB TEST NOW North Dallas Launches Web Portal for Background Checks 2Health News:Americans for Responsible Health Care Launch Ad Campaign in Massachusetts Senate Special Election Campaign 2
Formfit Ankle Stirrup with Foam Pads are Formfit Stirrup Ankle Braces with Revolutionary "Flex Edge" Technology....
... effective stirrup designed to truly function for both ... in profile than other stirrups, so it fits ... The X-Brace offers the Figure 8 X-Strap which ... foot. This allows the strapping of the midfoot ...
... fractures and Achilles ruptures are problem enough for ... of care and provide functional treatment for foot ... brings you the STORM. A combination of prefabricated ... freedom of movement with higher standards of safety. ...
... The Stabilizing Ankle support ... straps which lock the calcaneus ... abnormal eversion and inversion. The ... compression and stability. Ideal for ...
Medicine Products: